Cite
Leydig cell hyperplasia of ovary – An unusual finding in postneoadjuvant chemotherapy case of primary fallopian tube carcinoma.
MLA
Chaturvedi, Kriti, et al. “Leydig Cell Hyperplasia of Ovary – An Unusual Finding in Postneoadjuvant Chemotherapy Case of Primary Fallopian Tube Carcinoma.” Journal of Mid-Life Health, vol. 13, no. 3, July 2022, pp. 247–50. EBSCOhost, https://doi.org/10.4103/jmh.jmh_117_22.
APA
Chaturvedi, K., Rao, M., Saha, S., Vishnoi, J., & Nalwa, A. (2022). Leydig cell hyperplasia of ovary – An unusual finding in postneoadjuvant chemotherapy case of primary fallopian tube carcinoma. Journal of Mid-Life Health, 13(3), 247–250. https://doi.org/10.4103/jmh.jmh_117_22
Chicago
Chaturvedi, Kriti, Meenakshi Rao, Souvik Saha, Jeewan Vishnoi, and Aasma Nalwa. 2022. “Leydig Cell Hyperplasia of Ovary – An Unusual Finding in Postneoadjuvant Chemotherapy Case of Primary Fallopian Tube Carcinoma.” Journal of Mid-Life Health 13 (3): 247–50. doi:10.4103/jmh.jmh_117_22.